Literature DB >> 21091320

Short communication: persistence of high blood levels of the chemokines CCL2, CCL19, and CCL20 during the course of HIV infection.

Julie Fontaine1, Johanne Poudrier, Michel Roger.   

Abstract

Dendritic cells (DCs) are important mediators of the immune response against HIV and yet blood DC numbers fall substantially during HIV infection. Here we report that blood levels of the DC-tissue tropic chemokines monocyte chemotactic protein (MCP-1/CCL2), macrophage inflammatory proteins (MIP-3α/CCL20), and MIP-3β/CCL19 remained elevated throughout the course of HIV infection suggesting that the relatively low levels of blood circulating DCs may be due to active recruitment of these cells to peripheral sites to fight disease progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21091320     DOI: 10.1089/aid.2010.0261

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  18 in total

1.  CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals.

Authors:  C Loiseau; M Requena; M Mavigner; M Cazabat; N Carrere; B Suc; K Barange; L Alric; B Marchou; P Massip; J Izopet; P Delobel
Journal:  Mucosal Immunol       Date:  2016-02-17       Impact factor: 7.313

2.  CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Authors:  John N Aucott; Mark J Soloski; Alison W Rebman; Lauren A Crowder; Lauren J Lahey; Catriona A Wagner; William H Robinson; Kathleen T Bechtold
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

3.  Many Roles of CCL20: Emphasis on Breast Cancer.

Authors:  Kingsley O Osuala; Bonnie F Sloane
Journal:  Postdoc J       Date:  2014-03

Review 4.  Genetic variation and HIV-associated neurologic disease.

Authors:  Satinder Dahiya; Bryan P Irish; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virus Res       Date:  2013       Impact factor: 9.937

Review 5.  HIV persistence: chemokines and their signalling pathways.

Authors:  Vanessa A Evans; Gabriela Khoury; Suha Saleh; Paul U Cameron; Sharon R Lewin
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-28       Impact factor: 7.638

6.  Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.

Authors:  Jennifer M Zerbato; Erik Serrao; Gina Lenzi; Baek Kim; Zandrea Ambrose; Simon C Watkins; Alan N Engelman; Nicolas Sluis-Cremer
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

7.  Transcriptional Regulation of CXCL5 in HIV-1-Infected Macrophages and Its Functional Consequences on CNS Pathology.

Authors:  Debjani Guha; Cynthia R Klamar; Todd Reinhart; Velpandi Ayyavoo
Journal:  J Interferon Cytokine Res       Date:  2014-12-23       Impact factor: 2.607

8.  Macrophage Inflammatory Protein-3 Alpha (MIP-3α)/CCL20 in HIV-1-Infected Individuals.

Authors:  Najib Aziz; Roger Detels; L Cindy Chang; Anthony W Butch
Journal:  J AIDS Clin Res       Date:  2016-06-14

9.  Dendritic cell status modulates the outcome of HIV-related B cell disease progression.

Authors:  Johanne Poudrier; Michel Roger
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

Review 10.  Influence of dendritic cells on B-cell responses during HIV infection.

Authors:  Johanne Poudrier; Josiane Chagnon-Choquet; Michel Roger
Journal:  Clin Dev Immunol       Date:  2012-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.